Measuring Cell Growth in Human Tumors
Author Information
Author(s): G.D. Wilson, N.J. McNally, S. Dische, M.I. Saunders, C. Des Rochers, A.A. Lewis, M.H. Bennett
Primary Institution: Cancer Research Campaign, Gray Laboratory
Hypothesis
The study investigates the proliferative potential of human solid tumors using bromodeoxyuridine incorporation and flow cytometry.
Conclusion
The study found significant variability in cell proliferation rates among different tumors, with 38% having a potential doubling time of 5 days or less.
Supporting Evidence
- Both the labelling index and duration of S-phase varied greatly between tumors.
- Melanomas had the shortest S-phase duration of 8.8 hours.
- 38% of tumors had a potential doubling time of 5 days or less.
- The study included a spectrum of tumors from various sites.
Takeaway
Doctors can measure how fast cancer cells grow in tumors using a special dye, which helps them choose the best treatment for patients.
Methodology
Patients with solid tumors were injected with bromodeoxyuridine before biopsy, and cell proliferation was measured using flow cytometry.
Limitations
The study may not fully represent tumor heterogeneity as it relies on single biopsies.
Participant Demographics
Patients had a variety of solid tumors from different sites, including primary and metastatic cancers.
Want to read the original?
Access the complete publication on the publisher's website